Compare Lennar Corporation (LEN) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lennar Corporation vs Moderna, Inc. — how do they compare? Lennar Corporation trades at $87.37 (market cap $21.05B), while Moderna, Inc. trades at $60.77 (market cap $24.18B). The key difference: Lennar Corporation and Moderna, Inc. are close in size by market cap, and Lennar Corporation pays a 2.28% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| LEN | MRNA | |
|---|---|---|
Market Cap | $21.05B | $24.18B |
Sector | Consumer Cyclical | Health |
52-Week High | $142.40 | $81.80 |
52-Week Low | $81.84 | $22.36 |
Enterprise Value | $24.93B | $20.33B |
Dividend Yield | 2.28% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Lennar Corporation
Lennar is the second-largest public homebuilder in the United States. The company's homebuilding operations target first-time, move-up, and active adult homebuyers mainly under the Lennar brand name. Lennar's financial-services segment provides mortgage financing and related services to its homebuyers. Miami-based Lennar is also involved in multifamily construction and has invested in numerous housing-related technology startups.
Read more on LEN →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
